Sign in

NCT07198763Active, not recruiting

Comparison Between Conventional Rehabilitation and Conventional Rehabilitation Through Dance in Patients With COPD

Comparison Between Conventional Rehabilitation and Conventional Rehabilitation Through Dance in Patients With Chronic Obstructive Pulmonary Disease

Source: ClinicalTrials.gov · Last updated 30 Sept 2025

Brief summary (registry, in English)

Introduction: Chronic obstructive pulmonary disease (COPD) is recognized as one of the most relevant conditions worldwide, due to its high morbidity and mortality. Patients classified by GOLD as groups B and E are strongly encouraged to participate in pulmonary rehabilitation (PR) programs. Dance has been shown to be equally or, at times, more effective as a rehabilitation strategy when compared to other types of physical activity. Objective: To compare the effect of conventional rehabilitation and the effect of conventional rehabilitation added to dance in patients with COPD. Methods: This is a conventional randomized controlled clinical trial to be carried at the Piquet Carneiro University Polyclinic, Rio de Janeiro. Patients diagnosed with COPD will be evaluated. Eligible participants will complete specific questionnaires and tests. Finally, participants will be randomly divided into two groups: one group will perform conventional PR twice a week and the other group will perform rehabilitation through dance twice a week using 2 different playlists. The music will be from nationally and internationally known artists during 8 weeks. The evaluation tests will be repeated at the end of the intervention. Expected results: It is expected that the group of individuals with COPD who perform rehabilitation through dance will obtain greater and better results in relation to exercise capacity, QoL and peripheral muscle strength when compared to the group that will carry out the intervention consisting of two days of conventional PR. Keywords: Dance; Chronic obstructive pulmonary disease; Muscle strength; Quality of life; Rehabilitation.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
44 (actual)
First submitted
12 Sept 2025
Start date
7 Sept 2025
Primary completion date
7 Sept 2025
Lead sponsor
Centro Universitário Augusto Motta
Diseases
COPD
NCT number
NCT07198763

What you commit to

  • Study type: Interventional
  • Participants enrolled: 44
  • From 7 Sept 2025 to the primary completion date, 7 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous lung surgery;

Other illness

  • Presence of comorbidities and cardiovascular, neurological, renal, metabolic or musculoskeletal disorders that prevent the performance of functional tests;
  • Advanced cancer;

Other

  • Inability to understand functional tests or questionnaires applied;
  • Patients who, during the research, present an acute exacerbation of COPD, due to the time required for recovery;
  • Patients with results observed in the 6MWT \<300m.

Who the study is looking for

  • Patients who meet the diagnostic criteria for COPD;
  • Age group over 40 years old;
  • Both genders;
  • Absence of acute exacerbation in the last 30 days;
  • Patients who are regularly using their medications.

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Centro Universitário Augusto Motta
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.